Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System.
Completed
Conditions studied: Epilepsy, Seizures, Drug Resistant Epilepsy
In brief
Multicenter global post-market registry of subjects diagnosed with drug resistant epilepsy and treated with the VNS Therapy System.
Key facts
- Study ID
- NCT03529045
- Run by
- LivaNova
- People needed
- 827
- Starts
- 2018-02-05
- Expected to finish
- 2024-09-11
- Last updated by the study team
- 2024-11-22
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Clinical diagnosis of drug resistant epilepsy treated with VNS Therapy. Eligible subjects include those not previously treated with VNS Therapy as well as subjects receiving replacement generators.
- Able and willing to comply with the frequency of study visits.
- Subject, or legal guardian, understands study procedures and voluntarily signs an informed consent in accordance with institutional policies. In the event that the subject is under the age of 18, the subject may also be required (per EC/IRB) to sign an assent affirming their agreement to participate.
You may not qualify if…
- There are no exclusion criteria in this study. Investigators should refer to the local instructions for use for VNS Therapy.
Where it is running
- Georgetown University Medical Center — Washington D.C., District of Columbia, United States
- Research Institute of Orlando — Orlando, Florida, United States
- Pediatric Epilepsy & Neurology Specialists — Tampa, Florida, United States
- Hawaii Pacific Neuroscience — Honolulu, Hawaii, United States
- Via Christi Health — Wichita, Kansas, United States
- Tulane University — New Orleans, Louisiana, United States
- Dent Neurosciences Research Center — Amherst, New York, United States
- State University of New York — Syracuse, New York, United States
- Duke University Hospital — Durham, North Carolina, United States
- Wake Forest University — Winston-Salem, North Carolina, United States
- Hospital of the University of Pennsylvania — Philadelphia, Pennsylvania, United States
- Allegheny Neurology Associates — Pittsburgh, Pennsylvania, United States
- University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania, United States
- Le Bonheur Children's Hospital — Memphis, Tennessee, United States
- Child Neurology Consultants of Austin — Austin, Texas, United States
- University of Texas Health Science Center at San Antonio — San Antonio, Texas, United States
- Valley Health System — Winchester, Virginia, United States
- Ascension Columbia St. Mary's Hospital — Milwaukee, Wisconsin, United States
- Queensland Children's hospital — Brisbane, Queensland, Australia
- The Alfred Hospital — Melbourne, Victoria, Australia
- The Royal Melbourne Hospital — Melbourne, Victoria, Australia
- Royal Children's hospital — Melbourne, Victoria, Australia
- Perth Children's Hospital — Perth, Western Australia, Australia
- Kepler Universitätsklinikum — Linz, Austria
- St. Mary's Hospital — Grand Junction, Colorado, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.